We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
CSLR | Complete Solaria Inc | 0.7303 | 0.3494 | 91.73% | 25,796,069 |
MULN | Mullen Automotive Inc | 5.73 | 2.57 | 81.33% | 72,117,893 |
DCPH | Deciphera Pharmaceuticals Inc | 25.28 | 10.63 | 72.56% | 50,723,870 |
CAUD | Collective Audience Inc | 0.6377 | 0.2477 | 63.51% | 157,731,783 |
LICN | Lichen China Limited | 2.03 | 0.66 | 48.18% | 3,964,175 |
HWH | HWH International Inc | 2.5899 | 0.7699 | 42.30% | 35,335,185 |
VAXX | Vaxxinity Inc | 0.1579 | 0.0413 | 35.42% | 6,225,541 |
SINT | SiNtx Technologies Inc | 0.053477 | 0.01308 | 32.37% | 174,364,742 |
PAHC | Phibro Animal Health Corporation | 16.82 | 4.09 | 32.13% | 787,001 |
OLB | OLB Group Inc | 0.4768 | 0.1156 | 32.00% | 601,198 |
TSLL | Direxion Daily TSLA Bull 2X Trust ETF | 9.3599 | 2.21 | 30.91% | 83,228,982 |
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd. (ONO), under which ONO will acquire all outstanding shares of Deciphera common stock for $25.60 per share in cash through a tender offer followed by a merger of Deciphera with a wholly-owned subsidiary of ONO (the “Acquisition”), for a total equity value of $2.4 billion. The boards of directors of both companies have unanimously approved the transaction.
Zoetis Inc. (NYSE:ZTS) and Phibro Animal Health Corporation (Nasdaq: PAHC) today announced that they have entered into a definitive agreement where Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million, subject to customary closing adjustments. This transaction is expected to be complete in the second half of calendar year 2024.
HANGZHOU, China, April 29, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 0.9 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for aggregate gross proceeds of approximately $1.53 million. The closing of the sale of the securities is expected to occur on or about April 30, 2024, subject to ...
NEW YORK, April 29, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Heartland Financial, USA Inc. (NASDAQ: HTLF) and its board of directors concerning the proposed acquisition of the company by UMB Financial Corporation (NASDAQ: UMBF). Stockholders will receive 0.55 shares of UMB Financial common stock for each share of Heartland Financial stock that they hold. The transaction is valued at approximately $2 billion and is expected to close first quarter of 2025.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 63,443.06 | -394.75 | -0.62% | 1.24T | 4,057,571,471 |
ETH | Ethereum | 3,173.35 | -41.53 | -1.29% | 380.86B | 2,379,122,820 |
USDT | Tether USD | 0.99976 | 0.00011 | 0.01% | 97.82B | 273,703,792 |
BNB | Binance Coin | 596.65 | 4.11 | 0.69% | 94.34B | 278,343,390 |
SOL | Solana | 135.76 | -1.95 | -1.42% | 59.81B | 961,007,283 |
STETH | stETH | 3,171.50 | -41.46 | -1.29% | 31.07B | 5,562,750 |
XRP | Ripple | 0.5164 | 0.0014 | 0.27% | 28.21B | 297,165,919 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 1,092,389,907 |
DOGE | Dogecoin | 0.14295 | -0.00041 | -0.29% | 20.44B | 350,885,540 |
TONCOIN | Wrapped TON Coin | 5.34 | 0.029826 | 0.56% | 18.56B | 51,457,662 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions